Warning about sharp rise in illegal medicines sold in the EU

View source ↗

Summary

EMA warns that illegal medicines marketed as GLP-1 receptor agonists for weight loss and diabetes are circulating in the EU, posing serious health risks. The pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• illegal GLP-1 receptor agonists

Snippet

Illegal medicines marketed as GLP-1 receptor agonists for weight loss and diabetes pose serious risk to health